Fig. 3
Association of glucocorticoid use with early changes in markers of the systemic host immune response. p-values represent results from doubly robust inverse probability of treatment weighting analysis with each host response biomarker at follow-up as the outcome and with receipt of at least one dose of glucocorticoids between baseline and follow-up samples as the intervention. Unadjusted p-values are reported. *Denotes significance after adjusting for multiple comparisons by the method of Simes with a false discovery rate of 0.1. CI, confidence interval; Ang-2, angiopoietin-2; IL, Interleukin; ST-2, suppressor of tumorigenicity-2; sRAGE, soluble receptor of advanced glycation end-products; sTNFr1, soluble tumor necrosis factor receptor 1